Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

Factors affecting the response to gemfibrozil in hypertriglyceridemic continuous ambulatory peritoneal dialysis patients

Sohn SH, Kim HS, Choi KH, Lee HY, Han DS

  • KMID: 1694692
  • Korean J Nephrol.
  • 1992 Oct;11(3):270-278.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rhabdomyolysis Associated with Cerivastatin-Gemfibrozil Combination Therapy: 1 case

Kim SC, Kim MC, Ko YG

  • KMID: 2331339
  • J Korean Soc Emerg Med.
  • 2001 Dec;12(4):565-569.
Most currently available statins are associated with an increase with risk of myositis, including rhabdomyolysis. Myopathy is believed to be caused by interference in the cytochrome P450 3A4 enzyme system,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recurrent Rhabdomyolysis after Cerivastatin-Gemfibrozil Combination Therapy

Kim HS, Jeong CW, Sung J, Kim SR, Kim YK

  • KMID: 1611217
  • Korean J Nephrol.
  • 2002 Mar;21(2):322-326.
A 64-year-old woman with ischemic heart disease was admitted to our hospital because of both leg pain and difficulty to walk for 5 days. She had taken cerivastatin and gemfibrozil...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Type III Hyperlipoproteinemia Associate with Xanthoma Tuberosum and Xanthoma Striatum Palmare

Cho NJ, Lew W, Kim JH, Lee SH

  • KMID: 2230826
  • Korean J Dermatol.
  • 1994 Apr;32(2):321-326.
We report a case of type III hyperlipoproteinemia associated with xanthoma eruptivum. Xanthoma tuberosum, and xanthoma striatum palmare whose clinical symptoms have been improved by the treatment of gemfibrozil. A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of type IV Hyperlipoproteinemia with Xanthoma tuberosum and Xanthoma Eruptivum

Jung JW, Lee SC, Won YH, Chun IK

  • KMID: 1891554
  • Korean J Dermatol.
  • 1996 Aug;34(4):697-702.
We report a case of type IV hyperlipoproteinemia associated with xanthoma tuberosum and xanthoma eruptivum, which improved by treatment with gernfibrozil and procetofene. A 46-year-old male patient visited our clinic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Type V Hyperlipoproteinemia with Xanthoma Eruptivum

Lee SY, Lee WS, Chang SE, Choi JH, Sung KJ, Moon KC, Koh JK

  • KMID: 2086485
  • Korean J Dermatol.
  • 2001 Aug;39(8):935-937.
We report a case of type V hyperlipoproteinemia with xanthoma eruptivum associated with diabetes mellitus. An 18-year-old female patient presented with multiple, erythematous papules on the trunk, buttocks, and both...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Fibrate on Lipoprotein(a) Level in Hypertriglyceridemic Patients

Kim SJ, Lee KE, Lee SH, Jung KS, Lee KJ, Kim TH, Ko HS, Kim CJ, Ryu WS

BACKGROUND AND OBJECTIVES: The responses of lipoprotein (a) [Lp(a)] to lipid-lowering drugs are different from those of other lipids and lipoproteins. Most reports on the effect of fibrate on the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fenofibrate Therapy and Change of Renal Function: Management, What and How?

Kim SH

  • KMID: 2269333
  • Korean J Med.
  • 2014 Jun;86(6):698-701.
Fenofibrate is one of PPAR-alpha (peroxisome proliferator activated receptor alpha) agonists. Fenofibrate decreases effectively triglyceride and increases high density lipoprotein cholesterol level through the effect on lipoprotein lipase, hepatic production...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr